Amylyx Pharmaceuticals Inc(AMLX)
$31.80+0.89 (+2.88%)
AMLX
Amylyx Pharmaceuticals Inc earnings date
$31.80
At close:+0.89 (+2.88%)
Want to see AMLX full AI Analyst Report?
Amylyx Pharmaceuticals Inc (AMLX) Q2 2023 Earnings Report
723 Followers
AMLX Q2 2023 EPS Results
- Actual EPS
- $0.31
- Consensus EPS
- $0.19
- Beat/Miss
- Beat by +$0.12
- One Year Ago EPS
- -$0.93
AMLX Q2 2023 Revenue Results
- Actual Revenue
- $98.22M
- Expected Revenue
- $92.21M
- Beat/Miss
- Beat by +$6.00M
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/10/2023
- Time
- After Close
- Conference Call
- Thursday, August 10, 2023
AMLX Upcoming Earnings
Amylyx Pharmaceuticals Inc's next earnings date is estimated for March 9, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
AMLX Q2 2023 Earnings Call
0:00 / 0:00
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
AMLX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 09, 2027 | 2026 (Q4) | -0.38- | -0.3 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | -0.38-0.38 | -0.37 | -2.70% (-0.01) | |
| Aug 06, 2026 | 2026 (Q2) | -0.36-0.39 | -0.46 | 15.22% (+0.07) | |
| May 07, 2026 | 2026 (Q1) | -0.34-0.37 | -0.42 | 11.90% (+0.05) | |
| Mar 03, 2026 | 2025 (Q4) | -0.35-0.30 | -0.55 | 45.45% (+0.25) | |
| Nov 06, 2025 | 2025 (Q3) | -0.44-0.37 | -1.07 | 65.42% (+0.70) | |
| Aug 07, 2025 | 2025 (Q2) | -0.44-0.46 | -1.07 | 57.01% (+0.61) | |
| May 08, 2025 | 2025 (Q1) | -0.47-0.42 | -1.75 | 76.00% (+1.33) | |
| Mar 04, 2025 | 2024 (Q4) | -0.52-0.55 | 0.07 | -885.71% (-0.62) | |
| Nov 07, 2024 | 2024 (Q3) | -0.70-1.07 | 0.3 | -456.67% (-1.37) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
